Disclosures - Y. Kang: None. B. Bergmark: Research Support; Current; Amgen, Ionis, Pfizer, Philips, Inari, AstraZeneca, Abbott Vascular. Consultant; Current; Shockwave, Teleflex, Abbott Vascular, Abiomed, Bain Life Science, Morgan Stanley, SpectraWAVE, Bolt, Boston Scientific. V.J. Alexander: Employee; Current; Ionis Pharmaceuticals. T.A. Prohaska: Employee; Current; Ionis Pharmaceuticals. Stock/Shareholder; Current; Ionis Pharmaceuticals. X. Ran: Other - Institutional research grant to the TIMI Study Group at Brigham and Women’s Hospital to conduct the CORE trials; Current; Ionis Pharmaceuticals. Other - I am a member of the TIMI Study Group which has received institutional research grant support through Brigham and Women’s Hospital from Abbott, Abiomed, Inc., Amgen, Anthos Therapeutics, ARCA Biopharma, Inc., AstraZeneca, Boehringer Ingelheim, Cleerly, Inc., Daiichi-Sankyo, Janssen Research and Development, LLC, MedImmune, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Roche,; Current; other company. S. Murphy: Other - Institutional research grant to the TIMI Study Group at Brigham and Women’s Hospital to conduct the CORE trials; Current; Ionis Pharmaceuticals. Other - I am a member of the TIMI Study Group which has received institutional research grant support through Brigham and Women’s Hospital from Abbott, Abiomed, Inc., Amgen, Anthos Therapeutics, ARCA Biopharma, Inc., AstraZeneca, Boehringer Ingelheim, Cleerly, Inc., Daiichi-Sankyo, Janssen Research and Development, LLC, MedImmune, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Roche,; Current; Many - see Other field. E.L. Goodrich: Other - Institutional research grant to the TIMI Study Group at Brigham and Women’s Hospital; Current; Ionis Pharmaceuticals. F. Moura: None. A. Zimerman: Advisory Panel; Ended; Novartis Pharmaceuticals Corporation. Speaker's Bureau; Ended; Novartis Pharmaceuticals Corporation. E. Waldman: Employee; Current; Ionis Pharmaceuticals. J. Weinland: Employee; Current; Ionis Pharmaceuticals. Stock/Shareholder; Current; Ionis Pharmaceuticals. S. Zhang: None. S. Xia: Employee; Current; Ionis Pharmaceuticals. D. Li: None. S. Tsimikas: Employee; Current; Ionis Pharmaceuticals. R.P. Giugliano: Research Support; Current; Amgen Inc., Daiichi Sankyo, Ionis Pharmaceuticals, Novartis AG. Other - Honoraria for Academic Lectures / CME programs; Current; Amgen Inc., Daiichi Sankyo. Other - Honoraria for Academic Lectures / CME programs; Ended; Dr. Reddy’s Laboratories Ltd.. Other - Honoraria for Academic Lectures / CME programs; Current; Medical Education Resources. Other - Honoraria for Academic Lectures / CME programs; Ended; SUMMEET. Consultant; Current; Daiichi Sankyo, Inventiva Pharma. M.S. Sabatine: Other - Institutional research grant to the TIMI Study Group at Brigham and Women's Hospital; Consulting ; Current; Amgen Inc., AstraZeneca, Boehringer Ingelheim International GmbH. Research Support; Current; Inno Medicine, Ionis Pharmaceuticals, Marea. Other - Institutional research grant to the TIMI Study Group at Brigham and Women's Hospital; Consulting ; Current; Merck & Co., Inc.. Research Support; Current; Novartis AG, Pfizer Inc.. Consultant; Current; General Medicines. N. Marston: Research Support; Current; Ionis Pharmaceuticals. Advisory Panel; Current; Ionis Pharmaceuticals. Research Support; Current; Amgen Inc.. Advisory Panel; Current; Amgen Inc.. Research Support; Current; Marea Therapeutics. Advisory Panel; Current; Arrowhead Pharmaceuticals, Inc.. Advisory Panel; Ended; New Amsterdam. Advisory Panel; Current; Radence, Arboretum.

Yu Mi Kang

Brigham and Women’s Hospital/Harvard Medical School

Appearances